
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Bronchorrhea
Introduction
Bronchorrhea is the the production of more than 100 mL per day of watery sputum [1]. Chronic bronchitis is a common cause, but it may also be caused by asthma [2], bronchiectasis, tuberculosis, cancer, scorpion sting, organophosphate and other poisonings. Massive bronchorrhea may occur in either bronchioloalveolar cancer, or in metastatic cancer that is growing in a bronchioloalveolar pattern[1][3][4].
Differential Diagnosis of Bronchorrhea
Differential Diagnosis of Bronchorrhea
| Cardiovascular | No underlying causes |
| Chemical / poisoning | No underlying causes |
| Dermatologic | No underlying causes |
| Drug Side Effect | No underlying causes |
| Ear Nose Throat | No underlying causes |
| Endocrine | No underlying causes |
| Environmental | No underlying causes |
| Gastroenterologic | No underlying causes |
| Genetic | No underlying causes |
| Hematologic | No underlying causes |
| Iatrogenic | No underlying causes |
| Infectious Disease | No underlying causes |
| Musculoskeletal / Ortho | No underlying causes |
| Neurologic | No underlying causes |
| Nutritional / Metabolic | No underlying causes |
| Oncologic | No underlying causes |
| Opthalmologic | No underlying causes |
| Overdose / Toxicity | No underlying causes |
| Psychiatric | No underlying causes |
| Pulmonary | No underlying causes |
| Renal / Electrolyte | No underlying causes |
| Rheum / Immune / Allergy | No underlying causes |
| Trauma | No underlying causes |
| Miscellaneous | No underlying causes |
Treatment
Treatment
Treatment options include
- gefitinib – epidermal growth factor receptor tyrosine kinase inhibitor [5][6][7][8][9]
- indomethacin [10][11][12]
- corticosteroids [13]
- octreotide [14]
- radiation therapy [15]
References
References
- ↑ 1.0 1.1 Lembo T, Donnelly T (1995). “A case of pancreatic carcinoma causing massive bronchial fluid production and electrolyte abnormalities”. Chest. 108 (4): 1161–3. PMID 7555132.
- ↑ Shimura S, Sasaki T, Sasaki H, Takishima T (1988). “Chemical properties of bronchorrhea sputum in bronchial asthma”. Chest. 94 (6): 1211–5. PMID 2903819.
- ↑ Shimura S, Takishima T (1994). “Bronchorrhea from diffuse lymphangitic metastasis of colon carcinoma to the lung”. Chest. 105 (1): 308–10. PMID 8275762.
- ↑ Mito K, Yamakami Y, Kashima K, Mizunoe S, Tokimatsu I, Ichimiya T, Hiramatsu K, Nagai H, Kadota J, Nasu M (2002). “[A case of suspected lung metastasis of pancreatic carcinoma with bronchorrhea similar to bronchioloalveolar carcinoma]”. Nihon Kokyuki Gakkai Zasshi. 40 (8): 666–70. PMID 12428395.
- ↑ Kitazaki T, Soda H, Doi S, Nakano H, Nakamura Y, Kohno S (2005). “Gefitinib inhibits MUC5AC synthesis in mucin-secreting non-small cell lung cancer cells”. Lung Cancer. 50 (1): 19–24. PMID 16009452.
- ↑ Kitazaki T, Fukuda M, Soda H, Kohno S (2005). “Novel effects of gefitinib on mucin production in bronchioloalveolar carcinoma; two case reports”. Lung Cancer. 49 (1): 125–8. PMID 15949598.
- ↑ Milton D, Kris M, Gomez J, Feinstein M (2005). “Prompt control of bronchorrhea in patients with bronchioloalveolar carcinoma treated with gefitinib (Iressa)”. Support Care Cancer. 13 (1): 70–2. PMID 15558327.
- ↑ “Successful treatment of persistent bronchorrhea by gefitinib in a case with Recurrent Bronchioloalveolar Carcinoma: a case report”. World J Surg Oncol. 1 (1): 8. 2003. PMID 12917017.
- ↑ Yano S, Kanematsu T, Miki T, Aono Y, Azuma M, Yamamoto A, Uehara H, Sone S (2003). “A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (“Iressa”)”. Cancer Sci. 94 (5): 453–8. PMID 12824893.
- ↑ Tamaoki J, Kohri K, Isono K, Nagai A (2000). “Inhaled indomethacin in bronchorrhea in bronchioloalveolar carcinoma: role of cyclooxygenase”. Chest. 117 (4): 1213–4. PMID 10767270.
- ↑ Homma S, Kawabata M, Kishi K, Tsuboi E, Narui K, Nakatani T, Nakata K (1999). “Successful treatment of refractory bronchorrhea by inhaled indomethacin in two patients with bronchioloalveolar carcinoma”. Chest. 115 (5): 1465–8. PMID 10334175.
- ↑ Tamaoki J, Chiyotani A, Kobayashi K, Sakai N, Kanemura T, Takizawa T (1992). “Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis”. Am Rev Respir Dis. 145 (3): 548–52. PMID 1546834.
- ↑ Nakajima T, Terashima T, Nishida J, Onoda M, Koide O (2002). “Treatment of bronchorrhea by corticosteroids in a case of bronchioloalveolar carcinoma producing CA19-9”. Intern Med. 41 (3): 225–8. PMID 11929186.
- ↑ Hudson E, Lester J, Attanoos R, Linnane S, Byrne A (2006). “Successful treatment of bronchorrhea with octreotide in a patient with adenocarcinoma of the lung”. J Pain Symptom Manage. 32 (3): 200–2. PMID 16939841.
- ↑ Krawtz S, Mehta A, Vijayakumar S, Stoller J (1988). “Palliation of massive bronchorrhea”. Chest. 94 (6): 1313–4. PMID 2461277.
Editor-In-Chief: Template:Search infobox C. Michael Gibson, M.S., M.D. [1]
